We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Chancery Nixes Most Of Suit Over $600M DAVA-Endo Merger

Law360 (July 12, 2018, 7:01 PM EDT) -- The Delaware Chancery Court shut down all but one potential claim late Wednesday in a nearly four-year-old putative class suit over flawed approval warrants and deal disclosures issued in connection with DAVA Pharmaceuticals Inc.’s $600 million merger with Endo Pharmaceuticals Inc.

Chancellor Andre G. Bouchard concluded in a summary judgment that DAVA was able to tidy up objections raised by Cirillo Family Trust over failures to meet document requirements for voter warrants favoring the deal, such as missing signatures and dates. A Delaware law allowing after-the-fact...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.